The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...
Studies suggest that one-third to half of apnea patients either quit using a continuous positive airway pressure machine or never fill their prescription for it. One manufacturer was forced to pay ...